Published in PLoS Pathog on March 26, 2010
Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses. Biomed Res Int (2015) 1.43
Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J Exp Med (2012) 1.29
Pathogenesis of Lassa fever. Viruses (2012) 1.23
Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections. J Gen Virol (2013) 1.17
Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses. J Virol (2016) 1.06
Diagnostic proficiency and reporting of Lassa fever by physicians in Osun State of Nigeria. BMC Infect Dis (2014) 1.05
Functional interferon system is required for clearance of lassa virus. J Virol (2012) 1.05
Identification and characterization of genetically divergent members of the newly established family Mesoniviridae. J Virol (2013) 1.03
Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever. PLoS Negl Trop Dis (2011) 1.03
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection. PLoS Pathog (2015) 0.96
T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome. Viruses (2011) 0.94
Progress in the experimental therapy of severe arenaviral infections. Future Microbiol (2011) 0.90
Infection of type I interferon receptor-deficient mice with various old world arenaviruses: a model for studying virulence and host species barriers. PLoS One (2013) 0.90
Advanced vaccine candidates for Lassa fever. Viruses (2012) 0.90
Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure. PLoS Negl Trop Dis (2013) 0.87
Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials. PLoS Pathog (2013) 0.87
Immune responses and Lassa virus infection. Viruses (2012) 0.86
Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro. J Virol (2012) 0.86
Type I interferon is a therapeutic target for virus-induced lethal vascular damage. Proc Natl Acad Sci U S A (2014) 0.86
An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity. Virol J (2013) 0.86
Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus. J Virol (2013) 0.85
Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus. Virology (2013) 0.84
Severe hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virus. PLoS Negl Trop Dis (2012) 0.84
The search for animal models for Lassa fever vaccine development. Expert Rev Vaccines (2013) 0.84
Immune regulation and evasion of Mammalian host cell immunity during viral infection. Indian J Virol (2013) 0.79
Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model. Vaccine (2012) 0.79
Protective and Pathogenic Roles of CD8+ T Lymphocytes in Murine Orientia tsutsugamushi Infection. PLoS Negl Trop Dis (2016) 0.78
Pathogenic mechanisms involved in the hematological alterations of arenavirus-induced hemorrhagic fevers. Viruses (2013) 0.77
Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness. J Virol (2014) 0.77
Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever. PLoS Pathog (2016) 0.77
Determining Ribavirin's mechanism of action against Lassa virus infection. Sci Rep (2017) 0.75
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol (2003) 11.48
Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol (1969) 10.85
Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science (1990) 8.17
Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med (2003) 6.25
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med (2007) 5.58
A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27
Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg (1970) 4.96
IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev (2004) 4.78
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol (2003) 4.67
Exotic emerging viral diseases: progress and challenges. Nat Med (2004) 4.54
Antibody-enhanced dengue virus infection in primate leukocytes. Nature (1977) 4.18
Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA (1967) 4.01
In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis (1979) 3.90
Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int Immunol (1993) 3.73
A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51
Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol (2004) 3.04
HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med (1997) 3.03
Clinical virology of Lassa fever in hospitalized patients. J Infect Dis (1987) 2.94
CLEC5A is critical for dengue-virus-induced lethal disease. Nature (2008) 2.79
Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol (1995) 2.71
Development of a new vaccine for the prevention of Lassa fever. PLoS Med (2005) 2.71
Lassa virus. Crit Rev Clin Lab Sci (2004) 2.27
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol (1996) 2.26
Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14
The pathology of Lassa fever. Trans R Soc Trop Med Hyg (1972) 2.06
Vaccination for disease. Science (1991) 1.97
Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J Immunol (2004) 1.96
Mastomys natalensis and Lassa fever, West Africa. Emerg Infect Dis (2006) 1.94
Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev (2005) 1.94
Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis (2003) 1.91
Arenaviruses other than Lassa virus. Antiviral Res (2003) 1.86
Experimental studies of arenaviral hemorrhagic fevers. Curr Top Microbiol Immunol (1987) 1.83
Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis (2001) 1.79
An antiinflammatory role for IKKbeta through the inhibition of "classical" macrophage activation. J Exp Med (2008) 1.77
Effective vaccine for lassa fever. J Virol (2000) 1.74
Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect (2002) 1.71
Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis (2008) 1.65
Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression. J Med Virol (1999) 1.65
iNOS (NOS2) at a glance. J Cell Sci (2004) 1.51
Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol (1996) 1.51
Pathogenesis of Lassa virus infection in guinea pigs. Infect Immun (1982) 1.47
Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol (2006) 1.44
A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses. J Virol (2005) 1.42
Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol (2000) 1.42
In vivo lipid-derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDS. FASEB J (2002) 1.42
Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues. J Virol (2007) 1.41
Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J Infect Dis (2001) 1.40
Kinetics of protective antibodies are determined by the viral surface antigen. J Clin Invest (2004) 1.39
Lassa virus hepatitis: a study of fatal Lassa fever in humans. Am J Trop Med Hyg (1986) 1.31
Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J Virol (2004) 1.30
Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol (1995) 1.23
Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Trans R Soc Trop Med Hyg (1985) 1.17
Lassa virus hepatitis. Observations on a fatal case from the 1972 Sierra Leone epidemic. Arch Pathol (1975) 1.16
Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus. Lancet (1979) 1.14
The advent of the cytokine storm. Immunol Cell Biol (2007) 1.11
Identification of protective Lassa virus epitopes that are restricted by HLA-A2. J Virol (2006) 1.07
Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J Infect Dis (2004) 0.95
Isolation and antigenic characterization of Lassa virus. Nature (1970) 0.94
"Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self. J Clin Invest (2006) 0.93
Dengue vaccine: opportunities and challenges. IDrugs (2008) 0.88
Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development. Med Microbiol Immunol (1986) 0.88
Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome--relation to arterial hypotension and tumor necrosis factor. Infection (1997) 0.86
Lassa virus lethality for inbred mice. Ann Soc Belg Med Trop (1985) 0.83
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med (2014) 16.45
Physiology of microglia. Physiol Rev (2011) 6.99
Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol (2002) 6.60
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci (2007) 6.23
Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain (2005) 5.29
A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med (2014) 4.57
The immunopathology of multiple sclerosis: an overview. Brain Pathol (2007) 4.23
Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science (2006) 4.20
Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med (2011) 4.02
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity (2008) 3.67
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain (2011) 3.38
Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med (2008) 3.10
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain (2009) 3.04
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med (2011) 3.00
Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity (2009) 2.98
Disparate individual fates compose robust CD8+ T cell immunity. Science (2013) 2.80
Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet (2005) 2.68
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest (2006) 2.63
Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity (2010) 2.59
CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain (2009) 2.59
Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology (2005) 2.49
Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain (2007) 2.46
Remyelination is extensive in a subset of multiple sclerosis patients. Brain (2006) 2.43
Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J Neurosci (2011) 2.31
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain (2002) 2.27
Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci (2011) 2.25
Microglial phenotype: is the commitment reversible? Trends Neurosci (2006) 2.18
Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest (2006) 2.17
Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci U S A (2010) 2.15
RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene. Trans R Soc Trop Med Hyg (2007) 2.10
The alarmin interleukin-33 drives protective antiviral CD8⁺ T cell responses. Science (2012) 2.10
Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis. Brain (2005) 2.07
Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis (2009) 2.07
Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol (2002) 1.97
Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors. J Exp Med (2008) 1.94
Mastomys natalensis and Lassa fever, West Africa. Emerg Infect Dis (2006) 1.94
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc Natl Acad Sci U S A (2006) 1.92
Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis (2003) 1.91
Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res (2003) 1.82
Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on-pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection? Anesthesiology (2012) 1.81
Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA. Proc Natl Acad Sci U S A (2006) 1.79
Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci U S A (2006) 1.79
Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci (2002) 1.78
Inhibition of filovirus replication by the zinc finger antiviral protein. J Virol (2006) 1.76
Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect (2002) 1.71
Mechanisms of acute axonal degeneration in the optic nerve in vivo. Proc Natl Acad Sci U S A (2010) 1.70
Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol (2012) 1.70
Replicon system for Lassa virus. J Virol (2004) 1.69
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology (2012) 1.67
Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain (2006) 1.63
Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage. Brain (2007) 1.63
Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses. J Immunol (2012) 1.59
Microglia. Metab Brain Dis (2004) 1.58
Acute effects of intracranial hypertension and ARDS on pulmonary and neuronal damage: a randomized experimental study in pigs. Intensive Care Med (2011) 1.57
The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog (2010) 1.57
Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol (2003) 1.55
Epizootic emergence of Usutu virus in wild and captive birds in Germany. PLoS One (2012) 1.55
Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions. Exp Neurol (2006) 1.55
Isolation and phylogenetic analysis of Sindbis viruses from mosquitoes in Germany. J Clin Microbiol (2010) 1.55
Isolation of usutu virus in Germany. Am J Trop Med Hyg (2011) 1.55
Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis (2007) 1.53
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination. Acta Neuropathol (2012) 1.53
Microglia inflict delayed brain injury after subarachnoid hemorrhage. Acta Neuropathol (2015) 1.51
Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics. Anesthesiology (2007) 1.51
c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia (2005) 1.51
Sequence analysis of L RNA of Lassa virus. Virology (2004) 1.50
Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol (2007) 1.49
Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. Gastroenterology (2006) 1.46
Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA. J Clin Microbiol (2010) 1.45
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat Med (2010) 1.45
Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest (2008) 1.44
A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature (2012) 1.44
Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol (2013) 1.43
Evidence for a decrease in transmission of Ebola virus--Lofa County, Liberia, June 8-November 1, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.42
Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol (2007) 1.41
Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol (2004) 1.40
IkappaB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-kappaB in the central nervous system. Brain (2011) 1.37